Figure 1.
The Y139F VKORC1 mutant fully reduces KO to KH2to drive carboxylation. (A) Cycling between oxidized (KO) and reduced (KH2) vitamin K drives VKD protein carboxylation by the γ-glutamyl carboxylase. VKORC1 fully reduces KO to the quinone intermediate (K) and then to KH2; an unknown warfarin-resistant quinone reductase can also perform the second reaction. (B) Purified human VKORC1 bearing the Y139F mutation was tested for KO reduction to KH2 by performing all steps under nitrogen to block KH2 oxidation. (C) Microsomes containing only the carboxylase (Carb) or also expressing wt or Y139F VKORC1 were tested for KO or K supported carboxylation, as assessed by [14C]-CO2 incorporation into the peptide FLEEL. (D) The microsomes in panel C were also tested for KH2-supported carboxylation. (E) Insect cells containing tagged (Y139Fflag) and untagged Y139F or only the individual forms were subjected to immunopurification with anti-FLAG antibody, followed by western analysis using antibody against VKORC1, as before.22 Mock indicates uninfected cells.